• Home

  • News from the Lab

  • Research

  • Lab Members

    • Julie A Reisz
    • Rachel Culp-Hill
  • Publications

  • Technology

  • Collaborators

    • MIRAGES - RBC Atlas
  • Meetings

  • Teaching Material

  • Services

  • Outside the Lab

  • Sponsors

  • Contact us

  • More

    Use tab to navigate through the menu items.

    Research Catalyst

    • Facebook
    • Twitter Social Icon

    Our Recent Posts

    Scientists Discover Ways of Making Old Blood New Again

    Scientists Discover Ways of Making Old Blood New Again

    Travis, Davide and Angelo join Hemanext Inc and the Cancelas lab as recipients of the RISE Award

    Travis, Davide and Angelo join Hemanext Inc and the Cancelas lab as recipients of the RISE Award

    Angelo receives prestigious AABB NBF Award for Innovative Research

    Angelo receives prestigious AABB NBF Award for Innovative Research

    Archive

    • November 2021
    • December 2018
    • September 2018
    • May 2018
    • April 2018
    • January 2018
    • December 2017
    • November 2017
    • August 2017
    • May 2017
    • March 2017
    • December 2016
    • October 2016
    • September 2016
    • June 2016
    • February 2016
    • January 2016
    • October 2015
    • Home

    • News from the Lab

    • Research

    • Lab Members

      • Julie A Reisz
      • Rachel Culp-Hill
    • Publications

    • Technology

    • Collaborators

      • MIRAGES - RBC Atlas
    • Meetings

    • Teaching Material

    • Services

    • Outside the Lab

    • Sponsors

    • Contact us

    • More

      Use tab to navigate through the menu items.
      Top of the Page
      Scientists Discover Ways of Making Old Blood New Again

      Scientists Discover Ways of Making Old Blood New Again

      Restoring blood component regeneration process could curb disease, lengthen health span - by Debra Melani Creating 200 billion-plus...
      Travis, Davide and Angelo join Hemanext Inc and the Cancelas lab as recipients of the RISE Award

      Travis, Davide and Angelo join Hemanext Inc and the Cancelas lab as recipients of the RISE Award

      For the best paper in the journal Transfusion, focusing on the benefits of hypoxic storage of red blood cells on metabolism and...
      Angelo receives prestigious AABB NBF Award for Innovative Research

      Angelo receives prestigious AABB NBF Award for Innovative Research

      For his work on Omics applications in Transfusion Medicine
      Angelo receives prestigious ISBT Jean Julliard Award 2020

      Angelo receives prestigious ISBT Jean Julliard Award 2020

      For his work on High-Throughput Metabolomics in Transfusion Medicine: towards personalized medicine
      Attack on Red Blood Cells a Prime Suspect in COVID’s Debilitating Effects

      Attack on Red Blood Cells a Prime Suspect in COVID’s Debilitating Effects

      CU Researcher’s own coronavirus illness helps inform studies on body’s oxygen transporters - by Chris Casey Angelo D’Alessandro, PhD,...
      Tricking Mitochondria, the Cellular Powerhouse to Circumvent Chemotherapy Resistance

      Tricking Mitochondria, the Cellular Powerhouse to Circumvent Chemotherapy Resistance

      Researchers say, despite advancements in treatment, improving early therapy remains critical to cancer care - by Debra Melani Since a...
      How Can Slumbering Squirrels Inform Astronauts on Long-term Journeys?

      How Can Slumbering Squirrels Inform Astronauts on Long-term Journeys?

      Researchers show the animals have uniquely adapted to their extreme habitat by converting bodily waste products into nutrients during...
      Metabolomics: The Science Behind a two-times Tour de France Winner

      Metabolomics: The Science Behind a two-times Tour de France Winner

      CU research team’s platform measures how the body adapts during competition; has implications for treatments of cancer, diabetes,...
      Follow us on Twitter and Facebook!!!

      Follow us on Twitter and Facebook!!!

      Starting December 2018 we moved to Twitter and Facebook for our most recent updates!!!
      New effective drug combination for Acute Myeloid Leukemia

      New effective drug combination for Acute Myeloid Leukemia

      91% response rate to the combination of venetoclax with azacitidine in older adults newly diagnosed with acute myeloid leukemia (AML)"...
      1
      23

      ©2018 by D'Alessandro Lab